查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1807546

胰島素給藥裝置市場（按給藥方式、胰島素類型、分銷管道、最終用戶、應用和年齡層分類）—2025-2030 年全球預測

Insulin Delivery Devices Market by Delivery Method, Insulin Type, Distribution Channel, End User, Application, Age Group - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

胰島素輸送裝置市場預計到 2024 年將達到 315.2 億美元，到 2025 年將達到 338.6 億美元，到 2030 年將達到 496.5 億美元，複合年成長率為 7.86%。

主要市場統計數據
基準年2024年 315.2億美元
預計2025年 338.6億美元
預計2030年 496.5億美元
複合年成長率（%） 7.86%

透過最尖端科技、以患者為中心的使用者體驗和綜合治療解決方案，推動胰島素輸送裝置的革新

在技​​術突破和日益重視以患者為中心的醫療的推動下，胰島素輸送領域正在經歷重大變革。近年來，創新已將胰島素筆從簡單的機械裝置提升為整合數位監控功能的精密平台，而傳統注射器的設計也經過改進，以提高準確性並減輕患者不適。同時，胰島素幫浦已從傳統的有線系統發展為提供即時數據連接和閉合迴路控制的無線穿戴式技術，將慢性病管理轉變為無縫的個人化體驗。

描繪數位化、連結性和個人化治療方法推動的胰島素輸送技術的變革

隨著數位化和互聯互通與先進治療模式的融合，胰島素傳輸領域正經歷翻天覆地的變化。新型閉合迴路系統利用人工智慧，根據持續血糖監測動態調整劑量，增強患者自主性，減輕人工干預負擔。同時，行動醫療應用的普及使得無縫遠端監控成為可能，使臨床醫生能夠以前所未有的精細度調整治療方案，並在出現偏差時主動干預。

評估美國新關稅政策對胰島素輸送裝置供應鏈和成本結構的深遠影響

美國將於2025年開始實施新關稅，將對胰島素給藥裝置供應鏈產生多方面的影響。隨著關鍵零件進口關稅的提高，製造商面臨著不斷上升的投入成本，這些成本將透過製造外包協議和經銷商定價層層遞增。為此，許多醫療設備製造商正在重新審視其全球籌資策略，並考慮將關鍵組裝業務轉移到近岸外包，以降低其受不穩定國際貿易政策影響的風險。

解讀給藥方式、胰島素類型、通路、最終用戶、應用程式和年齡層等關鍵市場區隔的動態

對市場細分的細緻理解揭示了胰島素給藥生態系統中多樣化的需求和成長方向。根據給藥方式進行評估，市面上有各種各樣的產品，從強調劑量準確性和謹慎性的易於使用的胰島素筆，到具有無線連接功能的先進胰島素泵，以及傳統的胰島素注射器和新興的噴射式注射器，以滿足患者偏好和注射舒適度。每種方法都能夠應對依從性挑戰和臨床需求。

發現美洲、歐洲、中東和非洲以及亞太市場的區域成長模式和戰略機會

區域市場趨勢凸顯了各主要地理區域不同的策略要務。在美洲，強大的醫療基礎設施和報銷框架正在推動閉合迴路系統和數位醫療整合的快速普及，而密集的研發投入則持續推動著設備的改善。同時，付款人模式和基於價值的醫療計劃的轉變正在影響採購決策，並加速性價比評估。

剖析推動胰島素輸送裝置競爭格局的關鍵創新者和策略夥伴關係

競爭格局將由成熟的醫療設備領導者和敏捷的技術顛覆者決定。傳統製造商正利用數十年的胰島素給藥專業知識，推出具有增強連接性和以用戶為中心的功能的下一代注射筆和幫浦。同時，數位健康新興企業正在與製藥公司合作，將軟體主導的演算法和雲端基礎的分析技術整合到給藥平台中。

為行業領導者提供切實可行的見解和策略挑戰，以應對胰島素輸送中斷並推動永續成長

為了在快速發展的市場中取得成功，行業領導者應優先將高階分析和人工智慧整合到其設備平台中，以實現即時決策支援和預測性干預。透過區域生產基地實現生產佈局多元化，可以抵禦貿易政策波動，並提高供應鏈的敏捷性。此外，積極與付款人和監管相關人員互動，對於確保有利的報銷途徑和簡化設備核准至關重要。

嚴謹、多方面的調查方法為胰島素輸送裝置市場動態的全面分析奠定了基礎

本分析以嚴謹的調查方法為基礎，結合了質性和量性分析。原始數據透過與關鍵意見領袖、設備製造商和醫療保健提供者的深入訪談收集，並輔以一系列專家調查，以了解市場情緒和促進因素。二次研究涵蓋監管備案文件、同行評審文獻和公開的技術文檔，以確保全面了解設備規格和臨床性能。

關於創新、政策影響和市場趨勢交匯點的總結性觀點，這些因素將塑造胰島素輸送的未來

數位健康、政策變化和患者期望的不斷變化塑造並加速了胰島素給藥裝置的創新。隨著關稅重塑供應鏈和區域市場多元化，相關人員必須不斷調整其策略，以保持競爭優勢並創造價值。細分分析強調了針對各種給藥方式、胰島素製劑、分銷管道、最終用戶、臨床用途和年齡層進行客製化給藥的重要性。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概述

第5章市場動態

  • 具有藍牙連接功能、可提供即時劑量資訊的智慧胰島素筆的普及率正在上升
  • 在封閉回路型系統中整合連續血糖監測和自動胰島素輸送
  • 吸入式和口服胰島素製劑的出現，成為傳統注射裝置的替代品
  • 開發微針貼片技術，實現無痛精準胰島素注射
  • 提供遠端胰島素滴定和患者依從性監測的遠端醫療平台的成長
  • 擴大速效胰島素製劑的範圍，最佳化先進的幫浦相容性
  • 在胰島素輸送裝置中使用環保的生物分解性的藥筒組件
  • 新興市場需求推動低成本、可重複使用且具有簡化劑量功能的胰島素筆
  • 整合人工智慧演算法，實現個人化胰島素劑量和預測警報
  • 監管變化加快了下一代胰島素輸送技術的核准途徑

第6章 市場洞察

  • 波特五力分析
  • PESTEL分析

第7章 2025年美國關稅的累積影響

8. 胰島素輸送裝置市場（依輸送方式）

  • 胰島素筆
  • 胰島素幫浦
  • 胰島素注射器
  • 噴射注射器

9. 胰島素輸送裝置市場（依胰島素型態）

  • 中效型
  • 長效
  • 預混合料
  • 快速起效

10. 胰島素注射裝置市場（依通路）

  • 醫院藥房
  • 網路藥局
  • 零售藥局

第 11 章。胰島素輸送裝置市場（按最終用戶）

  • 門診治療中心
  • 診所
  • 居家照護環境
  • 醫院

12. 胰島素輸送裝置市場（依應用）

  • 妊娠糖尿病
  • 1型糖尿病
  • 2型糖尿病

第13章 胰島素輸送裝置市場（依年齡層）

  • 成人
  • 老年人
  • 小兒科

14.美國胰島素輸送裝置市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

15. 歐洲、中東和非洲胰島素注射裝置市場

  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 阿拉伯聯合大公國
  • 沙烏地阿拉伯
  • 南非
  • 丹麥
  • 荷蘭
  • 卡達
  • 芬蘭
  • 瑞典
  • 奈及利亞
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波蘭
  • 瑞士

16.亞太胰島素輸送裝置市場

  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 印尼
  • 泰國
  • 菲律賓
  • 馬來西亞
  • 新加坡
  • 越南
  • 台灣

第17章競爭格局

  • 2024年市場佔有率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Novo Nordisk A/S
    • B. Braun SE
    • Debiotech SA
    • Abbott Laboratories
    • Ascensia Diabetes Care Holdings AG
    • Owen Mumford Ltd.
    • Biocon
    • Eli Lilly and Company
    • Embecta Corp.
    • Gerresheimer AG
    • ICU Medical, Inc.
    • Insulet Corporation
    • Jiangsu Delfu medical device Co.,Ltd
    • Johnson & Johnson Services, Inc.
    • MannKind Corporation
    • Medtronic PLC
    • Nipro Corporation
    • Roche Diabetes Care, Inc.
    • Sanofi SA
    • Sequel Med Tech, LLC
    • SOOIL Developments Co., Ltd
    • Tandem Diabetes Care, Inc.
    • Terumo Corporation
    • Wockhardt Limited
    • Ypsomed AG

第18章 研究人工智慧

第19章 研究統計

第20章 研究聯絡人

第21章 研究報導

第22章 附錄

Product Code: MRR-ED54C46E8A4A

The Insulin Delivery Devices Market was valued at USD 31.52 billion in 2024 and is projected to grow to USD 33.86 billion in 2025, with a CAGR of 7.86%, reaching USD 49.65 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 31.52 billion
Estimated Year [2025] USD 33.86 billion
Forecast Year [2030] USD 49.65 billion
CAGR (%) 7.86%

Unveiling the Evolution of Insulin Delivery Devices with Cutting-Edge Technologies, Patient-Focused User Experiences, and Integrative Therapeutic Solutions

The landscape of insulin delivery has undergone a profound evolution, driven by technological breakthroughs and an intensified focus on patient-centric care. Over recent years, innovations have propelled insulin pens from simple mechanical devices into sophisticated platforms that integrate digital monitoring capabilities, while traditional syringes have seen design enhancements to improve precision and reduce patient discomfort. Meanwhile, insulin pumps have advanced from tethered systems into wireless, wearable technologies that offer real-time data connectivity and closed-loop control, transforming chronic disease management into a seamless, personalized experience.

This era of transformation has been further accelerated by an expanding clinical understanding of insulin pharmacodynamics and the pursuit of optimized glycemic control across diverse patient populations. As manufacturers and healthcare providers collaborate more closely, the integration of smart sensors, interoperable software ecosystems, and intuitive user interfaces is redefining expectations for safety, efficacy, and convenience. Consequently, stakeholders across the value chain must now navigate a dynamic environment where regulatory oversight, reimbursement frameworks, and patient advocacy intersect, shaping the strategic priorities of device developers and care delivery organizations alike.

Charting the Transformative Shifts in Insulin Delivery Technology Fueled by Digitalization, Connectivity, and Personalized Treatment Approaches

The insulin delivery arena is witnessing seismic shifts as digitalization and connectivity converge with advanced treatment paradigms. Emerging closed-loop systems are leveraging artificial intelligence to dynamically adjust dosage based on continuous glucose monitoring, elevating patient autonomy and reducing the burden of manual interventions. At the same time, the proliferation of mobile health applications has enabled seamless remote monitoring, empowering clinicians to tailor regimens with unprecedented granularity and to intervene proactively when deviations occur.

In parallel, there is a growing emphasis on modular device architectures that foster interoperability and future-proof investments. Developers are adopting open-platform standards to facilitate third-party integration of sensors, dosing algorithms, and telehealth services, creating an ecosystem where innovation can flourish through strategic partnerships. Moreover, multifunctional delivery devices are being designed to accommodate combination therapies and real-time biometric feedback, reflecting a holistic approach to diabetes management that transcends insulin alone. Together, these transformative shifts are setting new benchmarks for performance, patient adherence, and long-term clinical outcomes.

Assessing the Far-Reaching Ramifications of New United States Tariff Policies on Insulin Delivery Device Supply Chains and Cost Structures

The implementation of new tariff measures in the United States for 2025 is exerting a multifaceted impact on the insulin delivery device supply chain. As import duties on critical components rise, manufacturers are facing higher input costs that cascade through contract manufacturing agreements and distributor pricing structures. In response, many device producers are reevaluating their global sourcing strategies, considering nearshoring of key assembly operations to mitigate exposure to volatile international trade policies.

These shifts are not limited to raw materials alone; ancillary services such as calibration, software updates, and customer support are also subject to elevated expenses when conducted cross-border. Consequently, healthcare providers and payers are confronting pressure to absorb or negotiate additional costs, potentially affecting reimbursement negotiations and formulary placements. In anticipation of prolonged tariff regimes, industry participants are exploring vertical integration models, investing in domestic manufacturing capabilities, and forging strategic alliances to preserve supply chain resilience and maintain competitive pricing for end users.

Deciphering Key Market Segmentation Dynamics Across Delivery Methods, Insulin Types, Channels, End Users, Applications, and Age Groups

A nuanced understanding of market segmentation reveals the diverse needs and growth vectors within the insulin delivery ecosystem. When evaluating based on delivery method, offerings span from user-friendly insulin pens that emphasize dose accuracy and discretion to advanced insulin pumps equipped with wireless connectivity, alongside traditional insulin syringes and novel jet injectors that cater to patient preferences and injection comfort. Each modality addresses distinct adherence challenges and clinical requirements.

With respect to insulin type, distinctions emerge between intermediate-acting formulations prized for basal control, long-acting analogues designed for stable plasma profiles, pre-mixed preparations offering combination dosing, and rapid-acting variants engineered for postprandial glycemic spikes. These therapeutic classes influence device compatibility, dosing algorithms, and patient education strategies.

Distribution channels further differentiate market dynamics, encompassing hospital pharmacies that support acute and inpatient care, online pharmacies providing convenience and home delivery, and retail pharmacies serving outpatient populations. The interplay among these channels shapes procurement practices and patient access.

End users range from ambulatory care centers and specialty clinics to homecare settings and hospitals, each with specific device requirements, training needs, and service models. Application segments include gestational diabetes management protocols, intensive insulin regimens for type 1 diabetes, and adjustable dosing schedules for type 2 diabetes, reflecting varied clinical pathways. Finally, age group considerations-adult, geriatric, and pediatric-underscore the importance of ergonomic design, dosage precision, and user interfaces tailored to cognitive and dexterity capabilities across the lifespan.

Unearthing Regional Growth Patterns and Strategic Opportunities Across Americas, Europe Middle East Africa, and Asia Pacific Markets

Regional market behavior highlights distinct strategic imperatives across major geographic zones. In the Americas, robust healthcare infrastructure and reimbursement frameworks have driven rapid adoption of closed-loop systems and digital health integration, while concentrated R&D investments continue to spur incremental device enhancements. Meanwhile, shifting payer models and value-based care pilots are influencing procurement decisions and accelerating price-performance evaluations.

Within Europe, the Middle East, and Africa, regulatory harmonization efforts and cross-border trade agreements are shaping market entry strategies. Mature Western European markets emphasize clinical evidence and health technology assessments, whereas emerging markets in the Middle East and Africa present opportunities for cost-effective device variants and public-private partnerships to expand diabetes care access. Variability in reimbursement policies and economic heterogeneity necessitates tailored market approaches.

In Asia-Pacific, rising diabetes prevalence and expanding healthcare access are fueling demand for both basic and advanced delivery solutions. Nations with well-established healthcare systems are increasingly receptive to telemedicine-enabled pumps, while developing economies prioritize affordability and distribution network reach. Local manufacturing initiatives and government programs aimed at reducing out-of-pocket expenditure are further influencing competitive dynamics and innovation priorities.

Profiling Major Innovators and Strategic Partnerships Driving Competitive Advantage in the Insulin Delivery Device Landscape

The competitive landscape is defined by established medical device leaders and agile technology disruptors. Legacy manufacturers are leveraging decades of insulin delivery expertise to introduce next-generation pens and pumps with enhanced connectivity and user-centric features. Simultaneously, digital health startups are forging alliances with pharmaceutical companies to integrate software-driven algorithms and cloud-based analytics into delivery platforms.

Strategic partnerships between device producers and glucose monitoring innovators are yielding closed-loop ecosystems, while collaborations with telehealth providers are extending remote patient support capabilities. Investment in intellectual property around sensor miniaturization and secure data transmission is intensifying, as firms seek to protect differentiated offerings. Moreover, mergers and acquisitions are consolidating expertise across hardware, software, and service domains, shaping the competitive hierarchy and setting the stage for disruptive new entrants.

Actionable Insights and Strategic Imperatives for Industry Leaders to Navigate Disruption and Drive Sustainable Growth in Insulin Delivery

To thrive in a rapidly evolving market, industry leaders should prioritize the integration of advanced analytics and artificial intelligence into device platforms, enabling real-time decision support and predictive intervention. Diversification of manufacturing footprints through regional production hubs can safeguard against trade policy fluctuations and enhance supply chain agility. Additionally, proactive engagement with payer and regulatory stakeholders is essential to secure favorable reimbursement pathways and streamline device approvals.

Investing in patient education programs and digital literacy initiatives will bolster device adherence and foster brand loyalty. Collaborative research partnerships with academic and clinical institutions can accelerate the validation of novel delivery technologies, while strategic alliances with telemedicine providers can enhance post-market support services. Finally, exploring tailored solutions for underserved demographics and emerging markets will unlock new growth opportunities and reinforce corporate social responsibility commitments.

Rigorous Multidimensional Research Methodology Underpinning Comprehensive Analysis of Insulin Delivery Device Market Dynamics

This analysis was underpinned by a rigorous research framework combining qualitative and quantitative methodologies. Primary data was collected through in-depth interviews with key opinion leaders, device manufacturers, and healthcare providers, supplemented by a series of expert surveys to capture market sentiment and adoption drivers. Secondary research encompassed regulatory filings, peer-reviewed literature, and publicly available technical documentation, ensuring a comprehensive understanding of device specifications and clinical performance.

Data triangulation techniques were employed to validate findings across multiple sources, while trend extrapolation methods illuminated emerging patterns without relying on speculative forecasting. Validation workshops with multidisciplinary stakeholders provided a forum to refine insights and confirm strategic implications. This robust methodology ensures that the conclusions drawn reflect both the current state of the insulin delivery device market and the technological, regulatory, and economic forces shaping its trajectory.

Concluding Perspectives on the Intersection of Innovation, Policy Impact, and Market Trends Shaping the Future of Insulin Delivery

Innovation in insulin delivery devices is accelerating, shaped by the convergence of digital health, policy shifts, and evolving patient expectations. As tariffs reshape supply chains and regional markets diversify, stakeholders must continuously adapt their strategies to maintain competitive advantage and deliver value. Segmentation analysis underscores the importance of customizing offerings across delivery methods, insulin formulations, distribution channels, end users, clinical applications, and age demographics.

By aligning product development with regional healthcare imperatives and forging strategic partnerships across the digital ecosystem, manufacturers and care providers can optimize outcomes and expand access. The insights presented in this summary lay the groundwork for informed decision making, guiding investments in technology, manufacturing, and market entry to meet the demands of a dynamic insulin delivery landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Increasing adoption of smart insulin pens with Bluetooth connectivity for real-time dosing insights
  • 5.2. Integration of continuous glucose monitoring and automated insulin delivery in closed-loop systems
  • 5.3. Emergence of inhalable and oral insulin formulations as alternatives to traditional injection devices
  • 5.4. Development of microneedle patch technologies for painless and precise insulin administration
  • 5.5. Growth of telemedicine platforms offering remote insulin titration and patient adherence monitoring
  • 5.6. Expansion of ultra-rapid acting insulin formulations optimized for advanced pump compatibility
  • 5.7. Adoption of eco-friendly and biodegradable cartridge components in insulin delivery devices
  • 5.8. Emerging market demand driving low-cost reusable insulin pens with simplified dosing features
  • 5.9. Integration of artificial intelligence algorithms for personalized insulin dosing and predictive alerts
  • 5.10. Regulatory shifts enabling faster approval pathways for next-generation insulin delivery technologies

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Insulin Delivery Devices Market, by Delivery Method

  • 8.1. Introduction
  • 8.2. Insulin Pens
  • 8.3. Insulin Pumps
  • 8.4. Insulin Syringes
  • 8.5. Jet Injectors

9. Insulin Delivery Devices Market, by Insulin Type

  • 9.1. Introduction
  • 9.2. Intermediate-Acting
  • 9.3. Long-Acting
  • 9.4. Pre-Mixed
  • 9.5. Rapid-Acting

10. Insulin Delivery Devices Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Hospital Pharmacies
  • 10.3. Online Pharmacies
  • 10.4. Retail Pharmacies

11. Insulin Delivery Devices Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Care Centers
  • 11.3. Clinics
  • 11.4. Homecare Settings
  • 11.5. Hospitals

12. Insulin Delivery Devices Market, by Application

  • 12.1. Introduction
  • 12.2. Gestational Diabetes
  • 12.3. Type 1 Diabetes
  • 12.4. Type 2 Diabetes

13. Insulin Delivery Devices Market, by Age Group

  • 13.1. Introduction
  • 13.2. Adult
  • 13.3. Geriatric
  • 13.4. Pediatric

14. Americas Insulin Delivery Devices Market

  • 14.1. Introduction
  • 14.2. United States
  • 14.3. Canada
  • 14.4. Mexico
  • 14.5. Brazil
  • 14.6. Argentina

15. Europe, Middle East & Africa Insulin Delivery Devices Market

  • 15.1. Introduction
  • 15.2. United Kingdom
  • 15.3. Germany
  • 15.4. France
  • 15.5. Russia
  • 15.6. Italy
  • 15.7. Spain
  • 15.8. United Arab Emirates
  • 15.9. Saudi Arabia
  • 15.10. South Africa
  • 15.11. Denmark
  • 15.12. Netherlands
  • 15.13. Qatar
  • 15.14. Finland
  • 15.15. Sweden
  • 15.16. Nigeria
  • 15.17. Egypt
  • 15.18. Turkey
  • 15.19. Israel
  • 15.20. Norway
  • 15.21. Poland
  • 15.22. Switzerland

16. Asia-Pacific Insulin Delivery Devices Market

  • 16.1. Introduction
  • 16.2. China
  • 16.3. India
  • 16.4. Japan
  • 16.5. Australia
  • 16.6. South Korea
  • 16.7. Indonesia
  • 16.8. Thailand
  • 16.9. Philippines
  • 16.10. Malaysia
  • 16.11. Singapore
  • 16.12. Vietnam
  • 16.13. Taiwan

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Novo Nordisk A/S
    • 17.3.2. B. Braun SE
    • 17.3.3. Debiotech SA
    • 17.3.4. Abbott Laboratories
    • 17.3.5. Ascensia Diabetes Care Holdings AG
    • 17.3.6. Owen Mumford Ltd.
    • 17.3.7. Biocon
    • 17.3.8. Eli Lilly and Company
    • 17.3.9. Embecta Corp.
    • 17.3.10. Gerresheimer AG
    • 17.3.11. ICU Medical, Inc.
    • 17.3.12. Insulet Corporation
    • 17.3.13. Jiangsu Delfu medical device Co.,Ltd
    • 17.3.14. Johnson & Johnson Services, Inc.
    • 17.3.15. MannKind Corporation
    • 17.3.16. Medtronic PLC
    • 17.3.17. Nipro Corporation
    • 17.3.18. Roche Diabetes Care, Inc.
    • 17.3.19. Sanofi S.A.
    • 17.3.20. Sequel Med Tech, LLC
    • 17.3.21. SOOIL Developments Co., Ltd
    • 17.3.22. Tandem Diabetes Care, Inc.
    • 17.3.23. Terumo Corporation
    • 17.3.24. Wockhardt Limited
    • 17.3.25. Ypsomed AG

18. ResearchAI

19. ResearchStatistics

20. ResearchContacts

21. ResearchArticles

22. Appendix

LIST OF FIGURES

  • FIGURE 1. INSULIN DELIVERY DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 18. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 20. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 25. INSULIN DELIVERY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 26. INSULIN DELIVERY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 27. INSULIN DELIVERY DEVICES MARKET: RESEARCHAI
  • FIGURE 28. INSULIN DELIVERY DEVICES MARKET: RESEARCHSTATISTICS
  • FIGURE 29. INSULIN DELIVERY DEVICES MARKET: RESEARCHCONTACTS
  • FIGURE 30. INSULIN DELIVERY DEVICES MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. INSULIN DELIVERY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PENS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN SYRINGES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY JET INJECTORS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INTERMEDIATE-ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY INTERMEDIATE-ACTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY LONG-ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY LONG-ACTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRE-MIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PRE-MIXED, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RAPID-ACTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RAPID-ACTING, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GESTATIONAL DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 1 DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL INSULIN DELIVERY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 75. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. AMERICAS INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 89. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 90. UNITED STATES INSULIN DELIVERY DEVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 101. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. CANADA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 113. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. MEXICO INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 125. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. BRAZIL INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 137. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. ARGENTINA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 163. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. UNITED KINGDOM INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 165. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 166. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 167. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 169. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 170. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 171. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 173. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 174. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 175. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 176. GERMANY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 177. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 178. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 179. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 180. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 181. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 182. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 183. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 185. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 187. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. FRANCE INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 189. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 190. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 191. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 193. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 194. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 195. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 198. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 199. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 200. RUSSIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 201. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 202. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 203. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 205. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 206. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 207. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 211. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. ITALY INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 213. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 214. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 215. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 217. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 218. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 219. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 223. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. SPAIN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 242. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. SAUDI ARABIA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 254. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 259. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. SOUTH AFRICA INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 261. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 262. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 263. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 265. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 266. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 267. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 271. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 272. DENMARK INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 274. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 278. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 282. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 283. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 284. NETHERLANDS INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 285. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 286. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 287. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 288. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 289. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 290. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 291. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 295. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. QATAR INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 297. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 298. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 299. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 301. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 303. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 306. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 307. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 308. FINLAND INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 309. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 310. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 311. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 312. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MILLION)
  • TABLE 313. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 314. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 315. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 317. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 318. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 319. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 320. SWEDEN INSULIN DELIVERY DEVICES MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 321. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
  • TABLE 322. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
  • TABLE 323. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. NIGERIA INSULIN DELIVERY DEVICES MARKET SIZE, BY INSULIN TYPE, 2025-2030 (USD MI